KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Acquisitions (2016 - 2025)

Historic Acquisitions for Bristol Myers Squibb (BMY) over the last 15 years, with Q3 2025 value amounting to $1.9 billion.

  • Bristol Myers Squibb's Acquisitions rose 43850.57% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year decrease of 8978.3%. This contributed to the annual value of $21.8 billion for FY2024, which is 176663.82% up from last year.
  • Bristol Myers Squibb's Acquisitions amounted to $1.9 billion in Q3 2025, which was up 43850.57% from $285.0 million recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Acquisitions registered a high of $20.1 billion during Q1 2024, and its lowest value of $35.0 million during Q1 2021.
  • Moreover, its 5-year median value for Acquisitions was $348.0 million (2024), whereas its average is $1.6 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Acquisitions surged by 2560897.44% in 2024, and later tumbled by 9961.1% in 2025.
  • Bristol Myers Squibb's Acquisitions (Quarter) stood at $152.0 million in 2021, then fell by 23.68% to $116.0 million in 2022, then skyrocketed by 400.86% to $581.0 million in 2023, then tumbled by 91.91% to $47.0 million in 2024, then surged by 3887.23% to $1.9 billion in 2025.
  • Its last three reported values are $1.9 billion in Q3 2025, $285.0 million for Q2 2025, and $78.0 million during Q1 2025.